← Leaderboards
Francisco J Esteva
University Of Texas Md Anderson Can Ctr
$1,358,184
Attributed
$3,433,821
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $600.4K · FY2009–18$1M$750K$500K$250K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$3,433,821 · 6
By mechanism
R01$2,767,516 · 1
K23$544,320 · 1
P41$121,985 · 4
Top collaborators
- Stanislav Y Emelianov6 shared
- Kimberly Ann Homan6 shared
- Konstantin V Sokolov6 shared
Most similar at University Of Texas Md Anderson Can Ctr
Same institution · by research overlap
- Konstantin V Sokolov$9,178,408
- John D Hazle$5,935,389
- Albert B Deisseroth$3,595,581
- Gabriel Lopez-Berestein$9,617,602
- Nora M Navone$4,341,441
Others in their field
Top investigators on “Epidermal Growth Factor Receptor”
- Norman Wolmark · Nsabp Foundation, Inc.$27,726,714
- Walter John Curran · Thomas Jefferson University$26,641,549
- Robert J Coffey · Vanderbilt University$24,542,527
- Pasi A Janne · Stanford University$23,416,433
- John H Sampson · Duke University$21,673,210
- Jennifer R Grandis · University Of Pittsburgh At Pittsburgh$19,623,343
Research focus
Epidermal Growth Factor ReceptorResolutionMalignant Breast NeoplasmOverexpressionSignal TransductionResearch PersonnelBaseTumor ProgressionTissuesTumorMalignant NeoplasmsAustinAnimal Cancer ModelAthymic MouseAngiogenesisAlgorithmsCell PhysiologyAnticancer ResearchBreast NeoplasmsAntibodiesBiopsyBloodAntisense Nucleic AcidCancer Center
Grant awards (14)
Functional, cellular, and molecular imaging and therapy monitoring using ultrasou$241,896
R01 · FY2018 · CA
Functional, cellular, and molecular imaging and therapy monitoring using ultrasou$298,695
R01 · FY2017 · CA
Functional, cellular, and molecular imaging and therapy monitoring using ultrasou$544,193
R01 · FY2015 · CA
Functional, cellular, and molecular imaging and therapy monitoring using ultrasou$548,276
R01 · FY2014 · CA
Functional, cellular, and molecular imaging and therapy monitoring using ultrasou$534,022
R01 · FY2013 · CA
Functional, cellular, and molecular imaging and therapy monitoring using ultrasou$600,434
R01 · FY2012 · CA
DEGRADOMIC AND PEPTIDOMIC BIOMARKERS FOR EARLY-STAGE BREAST CANCER$28,669
P41 · FY2011 · RR · contact PI
FATTY ACID SYNTHASE AND EGFR/HER2 CROSS-TALK IN BREAST CANCER CELLS$28,669
P41 · FY2011 · RR · contact PI
FATTY ACID SYNTHASE AND EGFR/HER2 CROSS-TALK IN BREAST CANCER CELLS$32,124
P41 · FY2010 · RR · contact PI
FATTY ACID SYNTHASE AND EGFR/HER2 CROSS-TALK IN BREAST CANCER CELLS$32,523
P41 · FY2009 · RR · contact PI
LIPOSOMAL BCL-2 ANTISENSE THERAPY FOR SOLID TUMORS$136,080
K23 · FY2003 · CA
LIPOSOMAL BCL-2 ANTISENSE THERAPY FOR SOLID TUMORS$136,080
K23 · FY2002 · CA
LIPOSOMAL BCL-2 ANTISENSE THERAPY FOR SOLID TUMORS$136,080
K23 · FY2001 · CA
LIPOSOMAL BCL-2 ANTISENSE THERAPY FOR SOLID TUMORS$136,080
K23 · FY2000 · CA